The paradoxical association of common polymorphisms of the renin-angiotensin system genes with risk of myocardial infarction
暂无分享,去创建一个
P. Toutouzas | C. Stefanadis | J. Gialafos | G. Andrikopoulos | D. Richter | E. Gialafos | F. Kardaras | R. Mattu | S. Tzeis | E. Needham | S. Foussas | M. Zairis | E. Papasteriadis | Paraskeui G. Vogiatzi
[1] Christodoulos Stefanadis,et al. Risk stratification of coronary heart disease in Greece: final results from the CARDIO2000 Epidemiological Study. , 2002, Preventive medicine.
[2] Y. Bossé,et al. Influence of the angiotensin‐converting enzyme gene insertion/deletion polymorphism on lipoprotein/lipid response to gemfibrozil , 2002, Clinical genetics.
[3] P Toutouzas,et al. Risk Stratification of Coronary Heart Disease Through Established and Emerging Lifestyle Factors in a Mediterranean Population: CARDIO2000 Epidemiological Study , 2001, Journal of cardiovascular risk.
[4] P. Toutouzas,et al. In-hospital mortality of habitual cigarette smokers after acute myocardial infarction; the "smoker's paradox" in a countrywide study. , 2001, European heart journal.
[5] David R. Wood,et al. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. , 2001, European heart journal.
[6] K. Kohara,et al. Association of ACE I/D polymorphism with cardiovascular risk factors , 2000, Human Genetics.
[7] R. Abbate,et al. Searching for a better assessment of the individual coronary risk profile. The role of angiotensin-converting enzyme, angiotensin II type 1 receptor and angiotensinogen gene polymorphisms. , 2000, European heart journal.
[8] Sarah Parish,et al. Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls , 1999, The Lancet.
[9] A. Gotto,et al. Interactions between angiotensin-I converting enzyme insertion/deletion polymorphism and response of plasma lipids and coronary atherosclerosis to treatment with fluvastatin: the lipoprotein and coronary atherosclerosis study. , 2000, Journal of the American College of Cardiology.
[10] R. Gershoni-baruch,et al. The D allele of the angiotensin-converting enzyme gene contributes towards blood LDL-cholesterol levels and the presence of hypertension. , 1999, Atherosclerosis.
[11] A. Gardemann,et al. Angiotensin II type 1 receptor A1166C gene polymorphism. Absence of an association with the risk of coronary artery disease and myocardial infarction and of a synergistic effect with angiotensin-converting enzyme gene polymorphism on the risk of these diseases. , 1998, European heart journal.
[12] J. Staessen,et al. Genetic Variability in the Renin-Angiotensin System: Prevalence of Alleles and Genotypes , 1997, Journal of cardiovascular risk.
[13] D Kromhout,et al. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe , 1997 .
[14] A. Morice,et al. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of and prognosis after myocardial infarction. , 1996, Journal of the American College of Cardiology.
[15] Y. Yazaki,et al. Angiotensin converting enzyme polymorphism is associated with severity of coronary heart disease and serum lipids (total cholesterol and triglycerides levels) in Japanese patients. , 1996, Coronary artery disease.
[16] D. Wilcken,et al. Genotype distribution of angiotensin-converting enzyme polymorphism in Australian healthy and coronary populations and relevance to myocardial infarction and coronary artery disease. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[17] T. Wienker,et al. An angiotensin-converting enzyme gene variant is associated with acute myocardial infarction in women but not in men. , 1995, The American journal of cardiology.
[18] A. Marian,et al. Angiotensin-I converting enzyme genotype DD is a risk factor for coronary artery disease. , 1995, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.
[19] R Kreutz,et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. , 1995, The New England journal of medicine.
[20] P Ducimetière,et al. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction , 1994, The Lancet.
[21] G. Sagnella,et al. Angiotensin converting enzyme insertion/deletion polymorphism: association with ethnic origin , 1994, Journal of hypertension.
[22] J. Erikssen,et al. Insertion/deletion (I/D) polymorphism at the locus for angiotensin I‐converting enzyme and myocardial infarction , 1993, Clinical genetics.
[23] Philippe Amouyel,et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction , 1992, Nature.
[24] F. Soubrier,et al. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). , 1992, Nucleic acids research.
[25] P Corvol,et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. , 1990, The Journal of clinical investigation.
[26] S. Nanas,et al. Coronary heart disease risk factors in a random sample of Athenian adults. The Athens Study. , 1987, American journal of epidemiology.